RAPT Therapeutics | 4:持股变动声明-董事 Robbins Wendye
RAPT Therapeutics | 4:持股变动声明-董事 RIEFLIN WILLIAM JL
RAPT Therapeutics | 4:持股变动声明-董事 Lyons-Williams Lori
RAPT Therapeutics | 4:持股变动声明-董事 Kozick Linda
RAPT Therapeutics | 4:持股变动声明-董事 GRAY MARY ANN
RAPT Therapeutics | 4:持股变动声明-董事 Giordano Michael F
RAPT Therapeutics | 4:持股变动声明-董事 Robbins Wendye
RAPT Therapeutics | 4:持股变动声明-董事 GRAY MARY ANN
RAPT Therapeutics | 4:持股变动声明-董事 RIEFLIN WILLIAM JL
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(6.2%),Joseph Edelman(6.2%)等
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%)等
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(5.22%),Deep Track Biotechnology Master Fund, Ltd.(5.22%)等
RAPT Therapeutics | SC 13G:超过5%持股股东披露文件-The Vanguard Group(5.98%)
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(11.173%),Abigail P. Johnson(11.173%)
RAPT Therapeutics | 4:持股变动声明-高管 HO WILLIAM
RAPT Therapeutics | 4:持股变动声明-高管 Young Rodney KB
RAPT Therapeutics | 4:持股变动声明-高管 Brockstedt Dirk G.
RAPT Therapeutics | 4:持股变动声明-高管 Wong Brian Russell
RAPT Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(7.1%)
暂无数据